MX357648B - Vacuna antitumoral. - Google Patents
Vacuna antitumoral.Info
- Publication number
- MX357648B MX357648B MX2015002578A MX2015002578A MX357648B MX 357648 B MX357648 B MX 357648B MX 2015002578 A MX2015002578 A MX 2015002578A MX 2015002578 A MX2015002578 A MX 2015002578A MX 357648 B MX357648 B MX 357648B
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- relapse
- cancer disease
- tumor vaccination
- kill
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Radiology & Medical Imaging (AREA)
- Immunology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a una vacuna compuesta de al menos un estimulante inmune y ondas de radiofrecuencia utilizando acoplamiento capacitivo, y con un método, especialmente, un método de vacunación in vivo e in situ para el tratamiento del cáncer primario y su metástasis aun en estados celulares diseminados, que no pueden ser detectados por los métodos de imagenología disponibles actualmente o para la prevención de la recaída en el cáncer, y especialmente, para habilitar y apoyar al sistema inmune propio del paciente para reconocer y matar a las células cancerosas y generar una memoria para prevenir la recaída en un cáncer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12181821.5A EP2703001A1 (en) | 2012-08-26 | 2012-08-26 | Tumor vaccination |
US201261744008P | 2012-09-17 | 2012-09-17 | |
PCT/EP2013/067653 WO2014033097A1 (en) | 2012-08-26 | 2013-08-26 | Tumor vaccination |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015002578A MX2015002578A (es) | 2015-06-10 |
MX357648B true MX357648B (es) | 2018-07-18 |
Family
ID=46785268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015002578A MX357648B (es) | 2012-08-26 | 2013-08-26 | Vacuna antitumoral. |
Country Status (13)
Country | Link |
---|---|
US (1) | US10792483B2 (es) |
EP (2) | EP2703001A1 (es) |
JP (1) | JP2015530379A (es) |
KR (1) | KR101714281B1 (es) |
CN (1) | CN104640553A (es) |
AU (1) | AU2013307344B2 (es) |
CA (1) | CA2879739C (es) |
ES (1) | ES2586234T3 (es) |
HU (1) | HUE030407T2 (es) |
MX (1) | MX357648B (es) |
RU (1) | RU2015110690A (es) |
SG (1) | SG11201500396TA (es) |
WO (1) | WO2014033097A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2703001A1 (en) | 2012-08-26 | 2014-03-05 | XAX Kft. | Tumor vaccination |
US11911629B2 (en) | 2013-03-11 | 2024-02-27 | NeurEM Therapeutics, Inc. | Treatment of primary and metastatic brain cancers by transcranial electromagnetic treatment |
US11813472B2 (en) | 2013-03-11 | 2023-11-14 | NeuroEM Therapeutics, Inc. | Systems for sensing proper emitter array placement |
US11752356B2 (en) | 2013-03-11 | 2023-09-12 | NeuroEM Therapeutics, Inc. | Systems for controlling power to differently loaded antenna arrays |
US11759650B2 (en) | 2013-03-11 | 2023-09-19 | NeuroEM Therapeutics, Inc. | Immunoregulation, brain detoxification, and cognitive protection by electromagnetic treatment |
CN104491464A (zh) * | 2014-11-18 | 2015-04-08 | 四川金堂海纳生物医药技术研究所 | 一种治疗舌体干裂症的内服药物及制备方法 |
EP3515495A4 (en) * | 2016-09-26 | 2020-08-26 | Ensemble Group Holdings | METHOD OF EVALUATION AND TREATMENT OF CANCER IN HUMANS WITH DYSREGULATED LYMPHATIC SYSTEMS |
KR101856904B1 (ko) * | 2017-07-28 | 2018-05-11 | 동아대학교 산학협력단 | Pauf 단백질에 특이적으로 결합하는 항체 및 이의 용도 |
US11435351B2 (en) * | 2018-04-18 | 2022-09-06 | Biomadison, Inc. | Methods for determining vaccine potency |
US20220154219A1 (en) * | 2019-03-22 | 2022-05-19 | The Johns Hopkins University | Gene delivery particles to induce tumor-derived antigen presenting cells |
RU2722268C1 (ru) * | 2019-12-06 | 2020-05-28 | Федеральное государственное автономное образовательное учреждение высшего образования «Дальневосточный федеральный университет» (ДВФУ) | Способ биотерапии лабораторных крыс с перевитой глиобластомой |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57130920A (en) * | 1981-02-09 | 1982-08-13 | Zenyaku Kogyo Kk | Antitumor agent and its preparation |
JPS58157706A (ja) * | 1982-03-12 | 1983-09-19 | Norin Suisansyo Kajiyu Shikenjo | 果樹の摘花剤 |
JPS5936619A (ja) * | 1982-08-23 | 1984-02-28 | Tsumura Juntendo Inc | 制癌補助剤 |
US4712559A (en) * | 1985-06-28 | 1987-12-15 | Bsd Medical Corporation | Local current capacitive field applicator for interstitial array |
US5099756A (en) * | 1989-06-01 | 1992-03-31 | Harry H. Leveen | Radio frequency thermotherapy |
US7429471B2 (en) * | 2000-02-23 | 2008-09-30 | The Trustees Of The University Of Pennsylvania | Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
US6904323B2 (en) | 2003-05-14 | 2005-06-07 | Duke University | Non-invasive apparatus and method for providing RF energy-induced localized hyperthermia |
US7722857B2 (en) * | 2006-01-06 | 2010-05-25 | Cell-Medicine, Inc. | Immunoadjuvant |
US8019414B2 (en) * | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
US20090018613A1 (en) * | 2006-08-02 | 2009-01-15 | Genestim, Llc | Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields |
DE102006050369A1 (de) * | 2006-10-25 | 2008-04-30 | Oncotherm Kft. | Hyperthermievorrichtung für die selektive Behandlung und die Überwachung von Oberflächengewebe |
US9868768B2 (en) | 2008-01-25 | 2018-01-16 | Ruprecht-Karls-Universitat Heidelberg | Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver |
EP2082777A1 (en) | 2008-01-27 | 2009-07-29 | Oncotherm Kft. | Flexible and porous large-area electrode for heating |
EP2153866A1 (en) * | 2008-08-14 | 2010-02-17 | Oncotherm Kft. | Portable radiofrequency hyperthermia device with flexible treatment electrode for electric field capacitive coupled energy transfer |
EP2174689A1 (en) * | 2008-10-13 | 2010-04-14 | Oncotherm Kft. | Radiofrequency hyperthermia device with target feedback signal modulation |
EP2177336A1 (en) | 2008-10-17 | 2010-04-21 | Grupo Antolin-Ingenieria, S.A. | Method for manufacturing a vehicle trim panel |
GB2476315A (en) | 2009-12-21 | 2011-06-22 | Rec Wafer Norway As | Cleaning a stack of thin wafers |
EP2515995A1 (en) * | 2009-12-23 | 2012-10-31 | Hitops GmbH | New use of pulsed radio frequency |
EP2703001A1 (en) | 2012-08-26 | 2014-03-05 | XAX Kft. | Tumor vaccination |
-
2012
- 2012-08-26 EP EP12181821.5A patent/EP2703001A1/en not_active Withdrawn
-
2013
- 2013-08-26 WO PCT/EP2013/067653 patent/WO2014033097A1/en active Application Filing
- 2013-08-26 JP JP2015528982A patent/JP2015530379A/ja active Pending
- 2013-08-26 EP EP13756090.0A patent/EP2780024B1/en active Active
- 2013-08-26 SG SG11201500396TA patent/SG11201500396TA/en unknown
- 2013-08-26 AU AU2013307344A patent/AU2013307344B2/en not_active Ceased
- 2013-08-26 CA CA2879739A patent/CA2879739C/en active Active
- 2013-08-26 MX MX2015002578A patent/MX357648B/es active IP Right Grant
- 2013-08-26 ES ES13756090.0T patent/ES2586234T3/es active Active
- 2013-08-26 RU RU2015110690A patent/RU2015110690A/ru not_active Application Discontinuation
- 2013-08-26 US US14/424,027 patent/US10792483B2/en active Active
- 2013-08-26 CN CN201380044773.3A patent/CN104640553A/zh active Pending
- 2013-08-26 HU HUE13756090A patent/HUE030407T2/en unknown
- 2013-08-26 KR KR1020157005982A patent/KR101714281B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MX2015002578A (es) | 2015-06-10 |
RU2015110690A (ru) | 2016-10-20 |
KR20150043375A (ko) | 2015-04-22 |
AU2013307344B2 (en) | 2016-08-25 |
CA2879739A1 (en) | 2014-03-06 |
CA2879739C (en) | 2017-01-31 |
ES2586234T3 (es) | 2016-10-13 |
US10792483B2 (en) | 2020-10-06 |
CN104640553A (zh) | 2015-05-20 |
AU2013307344A1 (en) | 2015-02-26 |
EP2780024B1 (en) | 2016-05-25 |
WO2014033097A1 (en) | 2014-03-06 |
JP2015530379A (ja) | 2015-10-15 |
SG11201500396TA (en) | 2015-02-27 |
KR101714281B1 (ko) | 2017-03-09 |
US20150217099A1 (en) | 2015-08-06 |
EP2703001A1 (en) | 2014-03-05 |
EP2780024A1 (en) | 2014-09-24 |
HUE030407T2 (en) | 2017-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX357648B (es) | Vacuna antitumoral. | |
JOP20200192A1 (ar) | أجسام مضادة لـ tigit | |
MX2017003246A (es) | Macropinocitosis de anticuerpos anti-cd46 humanos y agentes terapeuticos dirigidos contra el cancer. | |
IL245113A0 (en) | Labeled inhibitors of prostate-specific membrane antigen (psma), their use as imaging agents and as pharmaceutical agents for the treatment of prostate cancer | |
EA201291195A1 (ru) | Усовершенствованная терапия рака на основе опухолеассоциированных антигенов, полученных из циклина d1 | |
MX2015010880A (es) | Combinacion de vacunacion e inhibicion de la trayectoria pd-1. | |
MX2021003858A (es) | Conjugados para el tratamiento de enfermedades causadas por celulas que expresan psma. | |
MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
RS20140202A1 (en) | BIOSPECIFIC IMMUNOVELING PROTEINS DIRECTED AGAINST TNF AND IL-17 | |
EP3126490A4 (en) | Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model | |
MX2013007657A (es) | Oligodesoxinucleotidos inmunoestimulantes. | |
EA201201464A1 (ru) | Новая комбинированная терапия для лечения онкологических и фиброзных заболеваний | |
PT4095130T (pt) | Inibidores marcados do antígeno de membrana específico da próstata (psma), seu uso como agentes de imagem e agentes farmacêuticos para o tratamento do cancro da próstata | |
EA201692100A1 (ru) | Новые антитела против rnf43 и способы их применения | |
MY179105A (en) | Methods of treating alzheimer's disease | |
MX2013013801A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
MX2013013800A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
MA40458A (fr) | Méthodes de traitement du cancer du col de l'utérus | |
WO2014200969A3 (en) | Methods of treatment of cancer | |
EA201891419A1 (ru) | Пептид-олигонуклеотидные конъюгаты | |
MX2016004212A (es) | Inhibidor de tor cinasa en la prevencion o tratamiento de cancer caracterizado por mutaciones genicas. | |
AP2012006181A0 (en) | Targeting PAX2 for the treatment of breast cancer. | |
EP3402484A4 (en) | PEPTIDE CONJUGATED NANOTEILES FOR TARGETING, IMPREGNATION AND TREATMENT OF PROSTATE CANCER | |
EP2879705A4 (en) | PEPTIDE VACCINES BASED ON THE EGFRVIII SEQUENCE FOR THE TREATMENT OF TUMORS | |
PH12014502464A1 (en) | Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |